drugset / Trial / NCT00722176
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Six-Week, Randomized, Double-Blind, Parallel Group Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 Compared To Risperidone, In Schizophrenic Patients Previously Treated In Study Bl-1020 Iib For A Maximum Of Six Weeks With Bl-1020 (High Dose, Low Dose), Risperidone Or Placebo
Timeline
- Start
- 2008-06
- Primary completion
- 2009-07
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PERPHENAZINE 4-AMINOBUTYRATE | Small molecule | 10 mg | Oral |
| Subject | PERPHENAZINE 4-AMINOBUTYRATE | Small molecule | 30 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 8 mg | Oral |